This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:physicians:concerns [06.01.2019] – [Read also] sallieq | home:physicians:concerns [06.05.2019] – [Read also] sallieq | ||
---|---|---|---|
Line 18: | Line 18: | ||
For some physicians, the above evidence is not sufficiently compelling to warrant automatically starting a patient on the MP without further consideration. Here are some other factors which may play a role in the clinical judgment: | For some physicians, the above evidence is not sufficiently compelling to warrant automatically starting a patient on the MP without further consideration. Here are some other factors which may play a role in the clinical judgment: | ||
* evidence for the efficacy of MP versus other available treatment options(({{pubmed> | * evidence for the efficacy of MP versus other available treatment options(({{pubmed> | ||
- | * more recent | + | * 2013 material on patient response, see section |
* patients' | * patients' | ||
* additional benefits of Olmesartan [[https:// | * additional benefits of Olmesartan [[https:// | ||
Line 117: | Line 117: | ||
{{tag> | {{tag> | ||
- | [[home: | + | [[home: |
===== Notes and comments ===== | ===== Notes and comments ===== | ||